Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 35, 3447-3449, November 1, 1975]
© 1975 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldsmith, E. I.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Goldsmith, E. I.

Formal Discussion of "Cancers of the Pancreas and Biliary Tract: Epidemiological Considerations"1

Edward I. Goldsmith

Department of Surgery, New York Hospital, Cornell Medical Center, New York, New York 10021

SUMMARIZING REMARKS: The present status of carcinoma of the pancreas is dismal and becoming worse because our treatment is not improving while incidence is increasing. Epidemiological data like those reported by Dr. Fraumeni have highlighted this situation and suggested some new ways to look at the disease.

High-risk groups in the population can be identified, but it is questionable whether screening is feasible with presently available diagnostic methods. If one recently published paper suggesting a tumor-specific protein is correct, it might become reasonable to explore such screening. Although surgical removal of these tumors has become safer and more effective and total pancreatectomy will be used more extensively in coming years, we cannot expect surgery to make an important impact on the disease since 90% of patients are inoperable when first seen.

Since prodromal and/or early malignant changes are not observable in human patients, we should turn vigorously to the creation of an animal model for biliary tract and/or pancreatic tumors. In this regard, existing evidence illustrates the close similarity of baboons to humans in bile chemistry and physiology. Furthermore, pancreatic cancer does occur in animals and suggests that carnivores and/or omnivores might be better candidates than herbivores to serve as animal models. Husbandry, management, and economic consideration make it entirely reasonable to turn to larger animals rather than mega-mice, if one is satisfied that phylogenetic similarity to humans and longer life-span are important.

It is reasonable to think that experimental studies following up on these epidemiological clues will produce useful data, and we can then hope that the coming years will produce better progress than we have made in our generation.

1 This discussion of the paper by Joseph F. Fraumeni, Jr. (Cancer Res., 35: 3437–3446, 1975) was presented at the Conference on Nutrition in the Causation of Cancer, May 19 to 22, 1975, Key Biscayne, Fla.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1975 by the American Association for Cancer Research.